Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed
Read More Pharma Industry News PRISM BioLab and Talus Bioscience aim to crack the transcription factor code with dual-platform drug discovery strategy PRISM BioLab and Talus Bio have teamed up to crack transcription factor drug discovery. Find out how their dual-platform strategy could reshape precision medicine. byVenkateshDecember 18, 2025